|
NFYA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84389947754937E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.24771329221585E-13 |
| Normal-vs-Stage2 |
6.74150002488716E-09 |
| Normal-vs-Stage3 |
3.42279538045887E-11 |
| Normal-vs-Stage4 |
6.97589985776403E-10 |
| Stage1-vs-Stage2 |
2.196200E-01 |
| Stage1-vs-Stage3 |
6.961700E-02 |
| Stage1-vs-Stage4 |
2.497000E-01 |
| Stage2-vs-Stage3 |
9.382000E-01 |
| Stage2-vs-Stage4 |
7.881200E-01 |
| Stage3-vs-Stage4 |
6.804200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.2117997150749E-10 |
| Normal-vs-AfricanAmerican |
8.394400E-04 |
| Normal-vs-Asian |
4.02170000002311E-06 |
| Caucasian-vs-AfricanAmerican |
1.879150E-01 |
| Caucasian-vs-Asian |
2.166400E-01 |
| AfricanAmerican-vs-Asian |
7.667600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55920054645264E-10 |
| Normal-vs-Female |
1.62714286489063E-12 |
| Male-vs-Female |
4.681400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.75359768109729E-11 |
| Normal-vs-Age(41-60Yrs) |
6.87228052242972E-14 |
| Normal-vs-Age(61-80Yrs) |
9.17244058484812E-12 |
| Normal-vs-Age(81-100Yrs) |
3.621000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.105370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.236370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.809400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.708600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.187600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.718200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.337300E-03 |
| Classical-VS-Follicular |
1.169240E-04 |
| Classical-VS-Other |
4.513200E-01 |
| Classical-VS-Normal |
4.55230000362405E-08 |
| Tall-VS-Follicular |
7.414000E-01 |
| Tall-VS-Other |
6.531600E-01 |
| Tall-VS-Normal |
3.7412994924324E-10 |
| Follicular-VS-Other |
6.104000E-01 |
| Follicular-VS-Normal |
1.82964754458226E-12 |
| Other-VS-Normal |
5.098500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.54871728961371E-15 |
| Normal-vs-N1 |
4.02970001811553E-09 |
| N0-vs-N1 |
9.340400E-01 |
|
|
